Safe implementation of the new oral anticoagulants (NOACs) requires patient monitoring

被引：0
|
作者：
Loizou, E. [1 ]
Toh, C-H [1 ]
Dutt, T. [1 ]
机构：
[1] Royal Liverpool Univ Hosp, Liverpool, Merseyside, England
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2014年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
COA05
引用
收藏
页码：9 / 9
页数：1
相关论文
共 50 条
  • [41] Monitoring new oral anticoagulants, managing thrombosis, or both?
    ten Cate, Hugo
    THROMBOSIS AND HAEMOSTASIS, 2012, 107 (05) : 803 - 805
  • [42] Monitoring oral anticoagulants: new strategies for an emerging problem
    Vittorio Pengo
    Internal and Emergency Medicine, 2006, 1
  • [43] Monitoring oral anticoagulants: new strategies for an emerging problem
    Pengo, Vittorio
    INTERNAL AND EMERGENCY MEDICINE, 2006, 1 (01) : 3 - 4
  • [44] Direct Oral Anticoagulants Correlation of Laboratory Monitoring With Safe Interventional Pain Procedures
    Benzon, Honorio T.
    Lindholm, Paul F.
    Huntoon, Marc A.
    REGIONAL ANESTHESIA AND PAIN MEDICINE, 2016, 41 (02) : 123 - 124
  • [45] New direct oral anticoagulants (DOAK) at the balancing act on the safe side
    Wulf, Hinnerk
    ANASTHESIOLOGIE INTENSIVMEDIZIN NOTFALLMEDIZIN SCHMERZTHERAPIE, 2014, 49 (03): : 172 - 173
  • [46] New oral anticoagulants Regional anaesthesia and new oral anticoagulants
    Standl, Thomas
    ANASTHESIOLOGIE INTENSIVMEDIZIN NOTFALLMEDIZIN SCHMERZTHERAPIE, 2014, 49 (03): : 192 - 195
  • [47] Non-vitamin-K oral anticoagulants (NOACs) for the prevention of secondary stroke
    Diener, Hans-Christoph
    Ntaios, George
    O'Donnell, Martin
    Easton, J. Donald
    EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (14) : 1597 - 1602
  • [48] Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? Results of a worldwide study
    Yang, H.
    Bouma, B. J.
    Dimopoulos, K.
    Khairy, P.
    Ladouceur, M.
    Niwa, K.
    Greutmann, M.
    Schwerzmann, M.
    Egbe, A.
    Scognamiglio, G.
    Budts, W.
    Veldtman, G.
    Opotowsky, A. R.
    Broberg, C. S.
    Gumbiene, L.
    Meijboom, F. J.
    Rutz, T.
    Post, M. C.
    Moe, T.
    Lipczynska, M.
    Tsai, S. F.
    Chakrabarti, S.
    Tobler, D.
    Davidson, W.
    Morissens, M.
    van Dijk, A.
    Buber, J.
    Bouchardy, J.
    Skoglund, K.
    Christersson, C.
    Kronvall, T.
    Konings, T. C.
    Alonso-Gonzalez, R.
    Mizuno, A.
    Webb, G.
    Laukyte, M.
    Sieswerda, G. T. J.
    Shafer, K.
    Aboulhosn, J.
    Mulder, B. J. M.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2020, 299 : 123 - 130
  • [49] NOVEL ORAL ANTICOAGULANTS (NOACS) VERSUS WARFARIN: INCIDENCE OF ISCHAEMIC STROKE EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION (AF) DESPITE ORAL ANTICOAGULANTS
    Iftikhar, H.
    Hendra, H.
    Saber, S.
    Keen, M.
    Umachandran, V.
    INTERNATIONAL JOURNAL OF STROKE, 2016, 11 (SUPP 3) : 250 - 250
  • [50] Laboratory Monitoring: A Turning Point in the Use of New Oral Anticoagulants
    Scridon, Alina
    Serban, Razvan C.
    THERAPEUTIC DRUG MONITORING, 2016, 38 (01) : 12 - 21
12345